<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated">
      <PMID Version="1">30557269</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>03</Month>
        <Day>06</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>03</Month>
        <Day>09</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1473-6578</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>32</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Mar</Month>
            </PubDate>
          </JournalIssue>
          <Title>Current opinion in psychiatry</Title>
          <ISOAbbreviation>Curr Opin Psychiatry</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Behavior and sleep disturbance in Smith-Magenis syndrome.</ArticleTitle>
        <Pagination>
          <StartPage>73</StartPage>
          <EndPage>78</EndPage>
          <MedlinePgn>73-78</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1097/YCO.0000000000000474</ELocationID>
        <Abstract>
          <AbstractText Label="PURPOSE OF REVIEW">To provide an update of the most recent studies on Smith-Magenis syndrome (SMS) with a focus on the unique pattern of behavioral and sleep disturbances associated with the condition.</AbstractText>
          <AbstractText Label="RECENT FINDINGS">The recent literature on SMS has focused on the characteristic severe behavioral and sleep disturbances. A better understanding of the underlying pathophysiological mechanisms and common clinical course has helped further characterize SMS, while much is left to be discovered in regard to effective treatment/management.</AbstractText>
          <AbstractText Label="SUMMARY">SMS is a difficult to manage genetic condition defined by pervasive and progressive behavioral and sleep disturbances with a unique pattern that can often be easily discerned from other neurodevelopmental disorders. Common behavioral features include maladaptive/self-injurious, aggressive, stereotypic, and the newly appreciated food seeking behaviors associated with SMS. In addition, there is a sleep disturbance defined by an altered circadian rhythm with frequent nighttime waking and daytime sleepiness, causing patients and families significant distress. Small studies have suggested some treatment/management approaches to the behavioral and sleep disturbances, however, much remains to be discovered.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Shayota</LastName>
            <ForeName>Brian J</ForeName>
            <Initials>BJ</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Molecular and Human Genetics, Baylor College of Medicine.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Texas Children's Hospital, Houston, Texas, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Elsea</LastName>
            <ForeName>Sarah H</ForeName>
            <Initials>SH</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Molecular and Human Genetics, Baylor College of Medicine.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>T32 GM007526</GrantID>
            <Acronym>GM</Acronym>
            <Agency>NIGMS NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Curr Opin Psychiatry</MedlineTA>
        <NlmUniqueID>8809880</NlmUniqueID>
        <ISSNLinking>0951-7367</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000374" MajorTopicYN="N">Aggression</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011599" MajorTopicYN="N">Psychopathology</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D020178" MajorTopicYN="Y">Sleep Disorders, Circadian Rhythm</DescriptorName>
          <QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
          <QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D058496" MajorTopicYN="Y">Smith-Magenis Syndrome</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
          <QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
          <QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013009" MajorTopicYN="N">Somnambulism</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013239" MajorTopicYN="N">Stereotyped Behavior</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <CoiStatement>Conflicts of interest. Dr. Elsea serves as Chair of the Professional Advisory Board for PRISMS, Inc., Parents and Researchers Interested in Smith-Magenis Syndrome and receives research funding from the Smith-Magenis Syndrome Research Foundation. There are no other conflicts of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>12</Month>
          <Day>18</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>3</Month>
          <Day>7</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>12</Month>
          <Day>18</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30557269</ArticleId>
        <ArticleId IdType="mid">NIHMS1518768</ArticleId>
        <ArticleId IdType="pmc">PMC6362978</ArticleId>
        <ArticleId IdType="doi">10.1097/YCO.0000000000000474</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Acquaviva F, Sana ME, Della Monica M, et al.
First evidence of Smith-Magenis syndrome in mother and daughter due to a novel RAI mutation. Am J Med Genet A. 2017;173(1):231–238.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27683195</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Girirajan S, Vlangos CN, Szomju BB, et al.
Genotype-phenotype correlation in Smith-Magenis syndrome: evidence that multiple genes in 17p11.2 contribute to the clinical spectrum. Genet Med. 2006;8(7):417–427.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16845274</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Edelman EA, Girirajan S, Finucane B, et al.
Gender, genotype, and phenotype differences in Smith-Magenis syndrome: a meta-analysis of 105 cases. Clin Genet. 2007;71(6):540–550.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17539903</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Smith AC, Pletcher BA, Spilka J, et al.
First report of two siblings with SMS due to maternal mosaicism. Poster session 829/C. New Orleans, LA: American Society of Human Genetics 56th Annual Meeting; 2006.</Citation>
        </Reference>
        <Reference>
          <Citation>Yang SP, Bidichandani SI, Figuera LE, et al.
Molecular analysis of deletion (17)(p11.2p11.2) in a family segregating a 17p paracentric inversion: implications for carriers of paracentric inversions. Am J Hum Genet. 1997;60:1184–93.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1712444</ArticleId>
            <ArticleId IdType="pubmed">9150166</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Park JP, Moeschler JB, Davies WS, et al.
Smith-Magenis syndrome resulting from a de novo direct insertion of proximal 17q into 17p11.2. Am J Med Genet. 1998;77:23–7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9557889</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gropman AL, Duncan WC, Smith AC. Neurologic and developmental features of the Smith-Magenis syndrome (del 17p11.2). Pediatr Neurol. 2006;34:337–50.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16647992</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Smith AC, Gropman AL. Smith-Magenis syndrome In: Cassidy S &amp; Allanson J, eds. Management of Genetic Syndromes. 3 ed. New York, NY: Wiley-Blackwell; 2010:739–67.</Citation>
        </Reference>
        <Reference>
          <Citation>Wolters PL, Gropman AL, Martin SC. Neurodevelopment of children under 3 years of age with Smith-Magenis syndrome. Pediatr Neurol. 2009. 
October;41(4):250–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2785222</ArticleId>
            <ArticleId IdType="pubmed">19748044</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Smith ACM, Boyd KE, Elsea SH, et al.
Smith-Magenis Syndrome
2001. 
October
22 [Updated 2012 Jun 28]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2018. Available from: https://www.ncbi.nlm.nih.gov/books/NBK1310/</Citation>
        </Reference>
        <Reference>
          <Citation>Hildenbrand HL, Smith AC. Analysis of the sensory profile in children with smith-magenis syndrome. Phys Occup Ther Pediatr. 2012;32:48–65.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21599572</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Finucane B, Haas-Givler B. Smith-Magenis syndrome: Genetic basis and clinical implications. J Ment Health Res Intel Disab. 2009;2:134–48.</Citation>
        </Reference>
        <Reference>
          <Citation>Sloneem J, Oliver C, Udwin O, Woodcock KA. Prevalence, phenomenology, aetiology and predictors of challenging behaviour in Smith-Magenis syndrome. J Intellect Disabil Res. 2011. 
February;55(2):138–51.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21199049</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Poisson A, Nicolas A, Cochat P, et al.
Behavioral disturbance and treatment strategies in Smith-Magenis syndrome. Orphanet J Rare Dis. 2015. 
September
4;10:111.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4559928</ArticleId>
            <ArticleId IdType="pubmed">26336863</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huisman S, Mulder P, Kuijk J, et al.
Self-injurious behavior. Neurosci Biobehav Rev. 2018. 
January;84:483–491.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28694012</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Alaimo JT, Barton LV 2, Mullegama SV, et al.
Individuals with Smith-Magenis syndrome display profound neurodevelopmental behavioral deficiencies and exhibit food-related behaviors equivalent to Prader-Willi syndrome. Res Dev Disabil. 2015. 
December;47:27–38. doi: 10.1016/j.ridd.2015.08.011.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ridd.2015.08.011</ArticleId>
            <ArticleId IdType="pubmed">26323055</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bissell S, Wilde L, Richards C, et al.
The behavioural phenotype of Potocki-Lupski syndrome: a cross-syndrome comparison J Neurodev Disord. 2018. 
January
10;10(1):2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5795277</ArticleId>
            <ArticleId IdType="pubmed">29329513</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Finucane B, Dirrigl KH, Simon EW. Characterization of self-injurious behaviors in children and adults with Smith-Magenis syndrome. Am J Ment Retard. 2001;106:52–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11246713</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sloneem J, Oliver C, Udwin O, Woodcock KA. Prevalence, phenomenology, aetiology and predictors of challenging behaviour in Smith-Magenis syndrome. J Intellect Disabil Res. 2011. 
February;55(2):138–51.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21199049</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Poisson A, Nicolas A, Cochat P, et al.
Behavioral disturbance and treatment strategies in Smith-Magenis syndrome. Orphanet J Rare Dis. 2015. 
September
4;10:111.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4559928</ArticleId>
            <ArticleId IdType="pubmed">26336863</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brennan A, Tysick J, Simon EW, Hamelin J. Smith-Magenis Syndrome. In: Griffiths D, Condillac R, Legree M, editors. Genetic Syndromes and Applied Behaviour Analysis: A Handbook for ABA Practitioners. London: Jessica Kingsley Publishers; 2014.  p. 147.</Citation>
        </Reference>
        <Reference>
          <Citation>Burns B, Schmidt K, Williams SR, et al.
Rai1 haploinsufficiency causes reduced Bdnf expression resulting in hyperphagia, obesity and altered fat distribution in mice and humans with no evidence of metabolic syndrome. Hum Mol Genet. 2010; 19, 4026–4042.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7714048</ArticleId>
            <ArticleId IdType="pubmed">20663924</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huang WH, Guenthner CJ, Xu J, et al.
Molecular and Neural Functions of Rai1, the Causal Gene for Smith-Magenis Syndrome. Neuron. 2016. 
October
19;92(2):392–406.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5098476</ArticleId>
            <ArticleId IdType="pubmed">27693255</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gray J, Yeo GS, Cox JJ, et al.
Hyperphagia, severe obesity, impaired cognitive function, and hyperactivity associated with functional loss of one copy of the brain-derived neurotrophic factor (BDNF) gene. Diabetes. 2006;55(12):3366–3371.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2413291</ArticleId>
            <ArticleId IdType="pubmed">17130481</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Falco M, Amabile S, Acquaviva F. RAI1 gene mutations: mechanisms of Smith-Magenis syndrome. Appl Clin Genet. 2017. 
November
3;10:85–94.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5680963</ArticleId>
            <ArticleId IdType="pubmed">29138588</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Williams SR, Zies D, Mullegama SV, et al.
Smith-Magenis syndrome results in disruption of CLOCK gene transcription and reveals an integral role for RAI1 in the maintenance of circadian rhythmicity. Am J Hum Genet. 2012. 
June
8;90(6):941–9</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3370274</ArticleId>
            <ArticleId IdType="pubmed">22578325</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nováková M, Nevsímalová S, Príhodová I, et al.
Alteration of the circadian clock in children with Smith-Magenis syndrome. J Clin Endocrinol Metab. 2012. 
February;97(2):E312–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22162479</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mullegama SV, Alaimo JT, Fountain MD, et al.
RAI1 overexpression promotes altered circadian gene expression and dyssomnia in Potocki-Lupski syndrome. J Pediatr Genet. 2017;6:155–164.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5548529</ArticleId>
            <ArticleId IdType="pubmed">28794907</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Boone PM, Reiter RJ, Glaze DG, et al.
Abnormal circadian rhythm of melatonin in Smith-Magenis syndrome patients with RAI1 point mutations. Am J Med Genet A. 2011;155A:2024–2027.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3140606</ArticleId>
            <ArticleId IdType="pubmed">21739587</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Spruyt K, Braam W, Smits M, Curfs LM. Sleep complaints and the 24-h melatonin level in individuals with Smith-Magenis syndrome: Assessment for effective intervention. CNS Neurosci. Ther. 2016, 22, 928–935.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6492880</ArticleId>
            <ArticleId IdType="pubmed">27743421</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Barboni M, Bueno C, Nagy BV. Melanopsin system dysfunction in Smith-Magenis syndrome patients. Invest Ophthalmol Vis Sci. 2018. 
January
1;59(1):362–369.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29346496</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Connor V, Zhao S, Angus R. Non-invasive ventilation for sleep-disordered breathing in Smith-Magenis syndrome. BMJ Case Rep. 2016. 
August
5;2016. pii: bcr2016215621.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4986049</ArticleId>
            <ArticleId IdType="pubmed">27495174</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Duncan WC, Gropman A, Morse R, et al.
Good babies sleeping poorly: Insufficient sleep in infants with Smith-Magenis syndrome. Am J Hum Genet. 2003;73 suppl:A896.</Citation>
        </Reference>
        <Reference>
          <Citation>Trickett J, Heald M, Oliver C, Richards C. A cross-syndrome cohort comparison of sleep disturbance in children with Smith-Magenis syndrome, Angelman syndrome, autism spectrum disorder, and tuberous sclerosis complex J Neurodev Disord. 2018;10(1):9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5831859</ArticleId>
            <ArticleId IdType="pubmed">29490614</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gropman AL, Elsea S, Duncan WC Jr, Smith AC. New developments in Smith-Magenis syndrome (del 17p11.2). Curr Opin Neurol. 2007;20(2):125–34.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17351481</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brendal MA, King KA, Zalewski CK, et al.
Auditory phenotype of Smith-Magenis syndrome. J Speech Lang Hear Res. 2017;14;60(4):1076–1087.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5548078</ArticleId>
            <ArticleId IdType="pubmed">28384694</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Laje G, Bernert R, Morse R, et al.
Pharmacological treatment of disruptive behavior in Smith-Magenis syndrome. Am J Med Genet C Semin Med Genet. 2010a;154C:463–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3022344</ArticleId>
            <ArticleId IdType="pubmed">20981776</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Smith AC, Magenis RE, Elsea SH. Overview of Smith-Magenis syndrome. J Assoc Genet Technol. 2005;31(4):163–7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16354942</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wilde L, Silva D, Oliver C. The nature of social preference and interactions in Smith-Magenis syndrome. Res Dev Disabil. 2013. 
December;34(12):4355–65</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24120292</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wilde L, Mitchell A, Oliver C. Differences in Social Motivation in Children with Smith-Magenis Syndrome and Down Syndrome. J Autism Dev Disord. 2016. 
June;46(6):2148–2159.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26983920</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wilde L, Oliver C. Brief Report: Contrasting Profiles of Everyday Executive Functioning in Smith-Magenis Syndrome and Down Syndrome. J Autism Dev Disord. 2017. 
August;47(8):2602–2609.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28500573</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hodapp RM, Fidler D, Smith A. Stress and coping in families of children with Smith–Magenis syndrome. J Intellect Disabil Res, 1998;42(5), 331–340.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9828063</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>De Leersnyder H, de Blois MC, Vekemans M, et al.
beta(1)-adrenergic antagonists improve sleep and behavioural disturbances in a circadian disorder, Smith-Magenis syndrome. J Med Genet. 2001. 
September;38(9):586–90.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1734944</ArticleId>
            <ArticleId IdType="pubmed">11546826</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>De Leersnyder H, Claustrat B, Munnich A, Verloes A. Circadian rhythm disorder in a rare disease: Smith-Magenis syndrome. Mol Cell Endocrinol. 2006. 
June
27;252(1–2):88–91.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16723183</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>De Leersnyder H, Claustrat B, Munnich A, Verloes A. Circadian rhythm disorder in a rare disease: Smith-Magenis syndrome. Mol Cell Endocrinol. 2006. 
June
27;252(1–2):88–91.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16723183</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Carpizo R, Martinez A, Mediavilla D, et al.
Smith-Magenis syndrome: a case report of improved sleep after treatment with beta1-adrenergic antagonists and melatonin. J Pediatr
2006;149:409–11.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16939758</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Van Thillo A, Devriendt K, Willekens D. [Sleep disturbances in Smith-Magenis syndrome: treatment with melatonin and beta-adrenergic antagonists]. [Article in Dutch]. Tijdschr Psychiatr. 2010;52(10):719–23.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20931486</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Baek WS, Elsea SH. Smith-Magenis Syndrome Treated with Ramelteon and Amphetamine-dextroamphetamine: Case Report and Review of the Literature. Case Report, J Genet Disor Genet Rep Vol: 5
Issue: 4</Citation>
        </Reference>
        <Reference>
          <Citation>Huang WH, Wang DC, Allen WE. Early adolescent Rai1 reactivation reverses transcriptional and social interaction deficits in a mouse model of Smith-Magenis syndrome. Proc Natl Acad Sci U S A. 2018. 
October
16;115(42):10744–10749.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6196530</ArticleId>
            <ArticleId IdType="pubmed">30275311</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
